Females have a higher odds of chronic rhinosinusitis (CRS) without nasal polyps than men, according to a study published ...

The approval for the CRSwNP indication was based on data from the randomized, double-blind, placebo-controlled WAYPOINT trial.

The U.S. Food and Drug Administration approved Tezspire (tezepelumab-ekko; Amgen) for the add-on maintenance treatment of inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP) in ...

Approval based on WAYPOINT Phase III results demonstrating reduced nasal polyp severity and nasal congestion, near-elimination of the need for surgery and significantly reduced systematic ...

Waking up with a stuffy nose is common and usually caused by allergies, nasal inflammation, post-nasal drip, sleep position ...

The patient - let's call her Melanie - in my consulting room looked absolutely mortified. 'What seems to be the problem,' I ...

Nasacort takes up to a week to achieve full benefits for allergy symptoms, and should be used daily for optimal allergy ...

AstraZeneca and Amgen have received U.S. Food and Drug Administration (FDA) approval for TEZSPIRE® (tezepelumab-ekko) as an add-on maintenance treatment for adults and adolescents aged 12 and ...

Treatment for chronic hives lasting at least 6 weeks may include one or more types of medication, as well as certain ...

Q. My father died of colon cancer back in 1999. His brother and sister both died of colon cancer too, so this is a big concern in our family.

Learn more about whether Alvotech or Arcus Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.